Plain-English translation of NCT06560047 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a procedure called catheter ablation—which uses heat to correct irregular heartbeats—works better than standard medications when given early to people who have both heart failure and atrial fibrillation (a common irregular heart rhythm). About 1,616 patients will be randomly assigned to either receive the ablation procedure within 6 weeks or to receive standard medical treatment for their heart rhythm problem. The goal is to find out which approach helps patients feel better and live longer.
People with both heart failure and irregular heartbeats have worse symptoms and poorer health outcomes, but doctors aren't sure whether the ablation procedure should be used as a first-line treatment or whether standard medications are better. This trial aims to settle that question with solid evidence.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the ablation group, you will undergo a catheter ablation procedure within 6 weeks of enrollment. If assigned to standard treatment, you will receive medications to help control your heart rhythm or rate as directed by your doctor. All participants will have one scheduled in-person visit at 12 months after enrollment, with additional routine follow-up care at your local hospital. The trial will track hospital visits, symptoms, medication changes, and heart rhythm information over time.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Denmark